Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation. 2017

Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
School of Pharmacy, Xinxiang Medical University, Xinxiang, Henan 453003, China.

Inhibition of lysine-specific demethylase 1 (LSD1) has recently emerged as an attractive therapeutic target for treating cancer and other diseases. As a continuity of our ongoing effort to identify novel small-molecule LSD1-inhibitors, we designed and synthesized a series of resveratrol derivatives, which were shown to be potent inhibitors of LSD1. Among them, compounds 4e and 4m displayed the most potent LSD1-inhibitory activities in enzyme assays, with IC50 values of 121 nM and 123 nM, respectively. Biochemistry study and docking analysis indicated that compounds 4e and 4m were reversible LSD1 inhibitors. High content analysis showed that 4e and 4m induced a dose-dependent increase of dimethylated Lys4 of histone H3 and had no impact on the expression of LSD1 in MGC-803 cells. Furthermore, 4e or 4m could remarkably increase the mRNA level of CD86, a surrogate cellular biomarker for LSD1 activity, in MGC-803 cells, suggesting that they are likely to exhibit LSD1-inhibitory activities intracellularly. These findings should encourage further modification of these compounds to produce more potent LSD1 inhibitors with potential anticancer activity.

UI MeSH Term Description Entries
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D056466 Histone Demethylases Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism. Histone Demethylase,Histone Lysine Demethylase,Histone Arginine Demethylases,Histone Lysine Demethylases,Arginine Demethylases, Histone,Demethylase, Histone,Demethylase, Histone Lysine,Demethylases, Histone,Demethylases, Histone Arginine,Demethylases, Histone Lysine,Lysine Demethylase, Histone,Lysine Demethylases, Histone
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
August 2021, European journal of medicinal chemistry,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
December 2019, Bioorganic & medicinal chemistry letters,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
February 2022, Archiv der Pharmazie,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
September 2021, Future medicinal chemistry,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
January 2019, European journal of medicinal chemistry,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
August 2012, Archives of pharmacal research,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
September 2015, Molecules (Basel, Switzerland),
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
June 2017, Bioorganic chemistry,
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
September 2019, Molecules (Basel, Switzerland),
Ying-Chao Duan, and Yuan-Yuan Guan, and Xiao-Yu Zhai, and Li-Na Ding, and Wen-Ping Qin, and Dan-Dan Shen, and Xue-Qi Liu, and Xu-Dong Sun, and Yi-Chao Zheng, and Hong-Min Liu
January 2021, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!